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A B S T R A C T
Hypertension is a common finding in end-stage renal disease patients with the prevalence between 20 to 85%. Al-
though the etiology of arterial hypertension (AH) in this patient group is multifactorial, sodium and volume excess lead-
ing to extracellular volume overload are one of the most important and potentially adjustable causes. Control of volume
status can either normalize the blood pressure (BP) or make the AH easier to control in the great majority of dialysis pa-
tients. Heavy reliance is placed on the dialysis procedure to gradually remove fluid over a period of days to weeks until a
stable dry weight is achieved. Numerous attempts have been made to utilize alternative methods to more accurately as-
sessment of dry weight, and the newest and most interesting method is multifrequency bioelectrical impedance spectros-
copy (BIS). In this prospective study we used BIS in 65 haemodialysis (HD) patients in order to detect those with vol-
ume-dependent hypertension and to further investigate the role of dry weight management in BP control. Dry weight was
corrected at the beginning, and after 1, and 3 months. Final data were collected after six months. Our data showed that
assessment of fluid overload using BIS provides better management of fluid status and BP control in the patients on
maintenance HD, and that dry weight correction can lead to significantly better control of volume-dependent hyperten-
sion in this patient group.
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Introduction
Hypertension is a common finding in end-stage renal
disease (ESRD) patients on maintenance dialysis. Based
upon multiple studies from 25 to 85% of ESRD patients
are hypertensive1,2. The etiology of hypertension in
ESRD is multifactorial3. Sodium and volume excess lead-
ing to extracellular volume overload are one of the most
important and potentially adjustable causes. Poorly con-
trolled hypertensive patients undergoing haemodialysis
(HD) are more likely to have large interdialytic weight
gain. Persistent hypertension in that group of patients
often reflects volume control that remains imperfect4,5.
Chronic volume overload causes left ventricular hyper-
trophy, while dehydration can cause intradialytic adverse
events, such a hypotension and cramps; both are linked
to an increased morbidity and mortality in this patient
population6,7. The diagnosis, objective quantification,
and management of this problem is integral in attempt-
ing to improve clinical outcomes, including mortality and
quality of life.
Control of volume status (VS) can either normalize
the blood pressure (BP) or make the hypertension easier
to control in the great majority of dialysis patients.
Heavy reliance is placed on the dialysis procedure to
gradually remove fluid over a period of days to weeks un-
til a stable dry weight is achieved8. Dry weight represent
the lowest (post-dialysis) weight patient can tolerate
without intradialytic symptoms or/and hypotension and
in the absence of overt fluid overload9. Numerous at-
tempts have been made to utilize alternative methods to
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more accurately assess dry weight. These include mea-
surements of the cardiothoracic index, inferior vena cava
diameter, plasma natriuretic peptide concentrations,
blood volume, and other parameters. However, these
methods are frequently impractical, subjective, are not
necessarily accurate, and a large prospective study has
not yet been performed that compares these methods to
clinical assessment alone10–13. The clinician must there-
fore define the dry weight and goal BP for each dialysis
patient based upon his or her best judgment and clinical
experience.
The most interesting and brand new method for esti-
mating VS, which is not in standard clinical practice yet,
is multifrequency bioelectrical impedance spectroscopy
(BIS). BIS measures at 50 frequencies (5 to 1000 kHz)
covering the entire beta-dispersion information, deter-
mines the electrical resistances of the total body water
and the extracellular water, and enables clear separation
between extracellular and intracellular water by the ex-
tremely wide range of measurement frequencies.
The aim of this prospective study was to detect HD
patients with volume-dependent hypertension by BIS,
and to further investigate the manner in which correc-
tion of volume overload can change BP in these patients.
Patients and Methods
The present prospective study was conducted from 1
November 2012 to 1 May 2013, at the Department of
Nephrology and Dialysis, Clinical Hospital Center Rije-
ka, Croatia. The study involved all ESRD patients on
maintenance HD for at least six months, three times a
week, four hours each treatment on biocompatible syn-
thetic (polysulfone) high-flux membranes. All patients
were older than 18 years, and signed the informed con-
sent approved by the local Ethics committee. Patients
who have been on peritoneal dialysis or transplanted be-
fore start of HD, patients with clinical and laboratory
signs of local or systemic inflammation, malignant dis-
ease, patients with permanent cardiac electrostimulator
or defibrillator, pregnant or breastfeeding women, pa-
tients with overt heart failure (NYHA grade 3 and 4) and
patients with one or more limb amputations were not in-
cluded in the study.
VS was assessed using a BIS method. Measurements
were performed using a Body Composition Monitor
(BCM – Body Composition Monitor, Fresenius Medical
Care, Bad Homburg, Germany), before the midweek HD
session at months 0, 1, 3 and 6 by experienced medical
nurse. BIS measurement was performed with the patient
in a supine recumbent position. After disinfection of pa-
tient’s fist and foot on the same body side, electrodes
were placed. Red and black electrodes were put on the
fist and same two on the foot, having in mind that red
electrodes always went distal. After that, patient was
connected to the BCM device and the measurement of
about three minutes was performed. The values of over-
hydration, extracellular water, intracellular water, total
body water, lean and adipose tissue mass were collected.
Results were taken as valid only if this operating quality
score was over 90%.
Experienced medical nurse measured at the begin-
ning and at the end of midweek HD session BP at
months 0, 1, 3 and 6. The same day VS was assessed by
BCM. Standardized Omron electronic BP monitor (Om-
ron M6; Omron Health Care Europe, Milton Keynes,
UK) with brachial cuff adjusted to the patient’s brachial
circumference was used for all measurements within the
study. BP was measured after patient’s repose in dura-
tion of 10 minutes in sitting position by taking measures
three times in a row, and the arithmetic mean for systolic
(BPsys) and diastolic BP was taken as a final value.
Dry weight was defined as the lowest weight a patient
can tolerate without the development of symptoms or
hypotension and according to cardiothoracic index and
clinical status14. The body weight before HD treatment,
and average daily diuresis were noted from the patient’s
HD record at the BCM and BP measurement day. Dialy-
sate sodium was adjusted to 140 mmol/l in all patients.
Patients with fluid overload more than 2.5 liters were
considered as hypervolemic, and those with fluid defi-
ciency more than –1.1 liters as hypovolemic. Patients
with systolic BP over 140 mmHg were considered as hy-
pertensive, and those with BPsys less than 100 mmHg as
hypotensive.
The data were used to generate a graphical tool,
hydration reference plot (HRP), which allows rapid diffe-
rentiation between hypotensive and hypertensive
patients as well as distinguishing fluid overload from the
state of normohydration. Depending on the BP and VS
patients were divided into five groups. The group one
consisted of patients with volume-dependent hyperten-
sion (BPsys>140 mmHg, OH>2,5 L), group two of pa-
tients with hypertension and normal volume status
(BPsys>140 mmHg, OH<2,5 L), group three consisted
of hypovolemic and hypotensive patients (BPsys<100
mmHg, A OH<–1,1 L), group four of hypervolemic but
normotensive patients (BPsys<140 mmHg, A OH>2,5
L), group five of normovolemic – normotensive patients
(BPsys<140 mmHg, OH<2,5 L). According to achieved
data dry weight and ultrafiltration rate at month 0, 1 and
3 were corrected. As patients serve as their own controls,
no normal values derived from healthy populations have
to be used for dry weight assessment. In the group two
the antihypertensive therapy was modified according to
the current guidelines.
Statistics
Statistical analysis of data was performed using de-
scriptive statistics (mean and standard deviation). Cate-
gorical variables were tested by chi-square test. Testing
the difference of two independent groups was performed
using t-test and ANOVA. P-value <0.05 was considered
to be statistically significant. Statistical analysis was
made using MedCalc statistical software package, ver-
sion 10 (MedCalc, Mariakerke, Belgium).
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Results
In the present study, 65 ESRD patients (36 male and
29 female) on maintenance HD mean age 61.1±13.9
years met inclusion criteria and were analyzed. The most
common etiology of ESRD in the included population was
non-diabetic nephropathy of vascular origin due to arte-
rial hypertension (28%). At the beginning of the study
49.2% of patients were normotensive (mean BPsys was
123±11 mmHg) and 50.8% were hypertensive (mean
BPsys 156±15 mmHg). After the follow-up of six months
78.5% were normotensive (mean BPsys 128±16 mmHg;
p<0.0001) and 21.5% were hypertensive (mean BPsys
142±19 mmHg; p=0.03). Although higher levels of he-
moglobin (Hb) could contribute to higher BP we found
neither significant difference in Hb levels after six months
and correlation between Hb levels, BP or hydration sta-
tus (data not shown). There were also no correlations be-
tween subgroups of patients based on the etiology of
ESRD, BP and VS. Table 1 provides a description of the
demographic characteristic of the 65 analyzed HD pa-
tients as well as comparison of data obtained on month 0
and 6.
On the first place, we were interested to detect those
patients that have volume-dependent hypertension since
correction of VS should lead to the better control of BP.
To that aim we assessed VS by BIS measurements and
data were interpolated with data on BP monitoring, as
we described in »Patients and Methods« section. Based
on these data patients were placed into five categories
(Figure 1). In the volume-dependent hypertension group
(group I) there were 22.5% patients while in the normo-
volemic hypertensive group (group II) there were 31% of
patients. Interestingly, there were no patients that fit in
the group III (hypovolemic and hypotensive patients).
There were only 9.5% of hypervolemic but normotensive patients (group IV) and 37% of patients were normovo-
lemic and normotensive (group V).
Next we were interested whether modification of dry
weight can lead to better control of hypertension espe-
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TABLE 1
DEMOGRAPHIC CHARACTERISTICS OF THE 65 PATIENTS ON
MAINTENANCE HAEMODYALISIS
Characteristic p








































* nondiabetic nephrop – non-diabetic nephropathy of vascular
origin, BP – blood pressure; The clinical data are obtained at the
beginning of the study, and after the follow up of six months.
Fig. 1. Hydration reference plot of 65 haemodialysis patients at
the beginning of the study.The regions within the plot allow dif-
ferentiation between normotensive, hypotensive, and hyperten-
sive patients as well as distinguishing fluid overload from the
state of normohydration. I – volume-dependent hypertension
(BPsys>140 mmHg, OH>2,5 L), II – hypertension and normal
volume status (BPsys>140 mmHg, OH<2,5 L), III – hypovole-
mic and hypotensive patients (BPsys<100 mmHg,A OH<–1,1
L), IV – hypervolemic but normotensive patients (BPsys<140
mmHg,A OH>2,5 L), V – normovolemic – normotensive patients
(BPsys<140 mmHg, OH<2,5 L).
Fig. 2. Hydration reference plot of 65 haemodialysis patients af-
ter six months. I – volume-dependent hypertension (BPsys>140
mmHg, OH>2,5 L), II – hypertension and normal volume status
(BPsys>140 mmHg, OH<2,5 L), III – hypovolemic and hypoten-
sive patients (BPsys<100 mmHg,A OH<–1,1 L), IV – hypervo-
lemic but normotensive patients (BPsys<140 mmHg,A OH>2,5
L), V – normovolemic – normotensive patients (BPsys<140 mm
Hg, OH<2,5 L).
cially in the volume-dependent hypertension patients.
According to data of VS obtained by BIS and BP data, dry
weight and ultrafiltration rate were corrected at month
0, 1 and 3 (data not shown). After the six months we per-
formed final measurements that were compared with the
initial data. The data are depicted on the figure 2. In the
group I and II there were statistically significant de-
crease of patients: –16.3% for group I (p=0.04) and
–15.7% (p=0.03). The reduction of patients in the hyper-
volemic normotensive group was – 4.9% but this was not
statistically significant (p=0.9), while in the fifth group
there were 36.9% patients more and this was highly sta-
tistically significant (p<0.0001).
Discussion
The purpose of this study was to evaluate BIS method
as a tool in detection of volume-dependent hypertensive
patients on maintenance hemodialysis. Furthermore, by
using the data on overhydration obtained with BIS we
want to intervene in fluid overloaded patients in order to
achieve better dry weight and BP control.
Assessment of dry weight in everyday clinical practice
is mainly based on the assessment of cardiothoracic in-
dex, peripheral edema, and clinical status of the patient
but these are very subjective and often not accurate eval-
uation methods. Numerous attempts have been made to
utilize alternative methods to more accurately assess dry
weight. Therefore, there is a lot of effort in developing,
testing and validation of new, more useful and precise
methods. Several new methods for determination of dry
weight based on bioelectrical impedance have been devel-
oped in recent years. Although none of these methods
has been widely used in clinical practice so far, BIS has
been the most promising novel technique used for dry
weight determination, and BP control in dialysis popula-
tion group15,16.
Based on the BP values and BIS data on overhy-
dration we were able to stratified patients into five
groups according to previously published study17. The
vast majority of patients were hypertensive and 22.5 % of
all patients appeared to have volume-dependent hyper-
tension. That was more in comparison to previously
mentioned study by Wabel et al where just 15% of stud-
ied HD patients had volume-dependent hypertension.
Greater proportion of patients (31%) were hypertensive
but norm hydrated indicating that hypertension in the
ESRD population was not exclusively volume-dependent,
and could represent essential hypertension, as shown in
the study of Kooman JP et al.18. One of the reasons for
the high prevalence of arterial hypertension in dialysis
patients might be the way physicians treat arterial hy-
pertension once it has been diagnosed. It is also worth
noting that 9.5 % of studied patients were overhydrated
but normotensive.
The HRP we used, provided an invaluable tool for
classifying patients in terms of BPsys and VS, and the
proximity of these parameters to reference ranges19.
These both were effective, useful and safe tools for esti-
mating the right modality of BP control in these patient
groups.
By modifying dry weight by ultrafiltration on month
0, 1, and 3 we were able to obtain statistically significant
reduction of proportion of patients have been in vol-
ume-dependent hypertension group. However, after six
months there were still 6.5% patients that have vol-
ume-dependent hypertension independently of our effort
to achieve dry weight. These were group of uncoopera-
tive patient that had usually more than four kilogram of
interdialytic weight gain. Once we have identified pa-
tients with volume-dependent hypertension, we were
able to maintain dry weight in norm hydrated hyperten-
sive patients and to achieve better BP control by modifi-
cation of antihypertensive therapy. By this approach, we
were able to halve this group of patients. Interestingly,
although not statistically significant, we were also able to
reduce the proportion of patients within overhydrated
normotensive group by raising their dry weight while
still preserve normal BP.
Limitations of our study were the small number of en-
rolled subjects and the heterogeneity of the studied group.
Conclusion
Our data showed that assessment of fluid overload us-
ing BIS provides better management of fluid status and
BP control in the patients on maintenance HD. It is safe,
reproducible and objective tool that should restrict the
practice of probing dry weight in HD patients. Once dry
weight can be reliably and reproducibly determined by
bioimpedance technology, BCM may become also a pow-
erful tool for BP control during HD. Further refinement
of the methods as well as large-scale clinical studies to
demonstrate the accuracy of objective dry weight mea-
sures, and to prove the long-term clinical value of dry
weight achievement, are needed.
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»BCM – BODY COMPOSITION MONITOR«: NOVI URE\AJ ZA DIJAGNOSTIKU HIPERTENZIJE
OVISNE O VOLUMENU U BOLESNIKA NA REDOVITOJ HEMODIJALIZI
S A @ E T A K
Hipertenzija je ~est nalaz u bolesnika u zavr{nom stadiju kroni~ne bubre`ne bolesti s u~estalo{}u od 20 do 85%. Iako
etiologija nastanka arterijske hipertenzije u toj skupini bolesnika ovisi o vi{e ~imbenika, vi{ak vode i soli vodi u hipervo-
lemiju. Na navedene ~imbenike, s druge strane, mo`emo najlak{e utjecati te ih korigirati. Korekcijom volumnog statusa
(VS) mo`emo normalizirati krvni tlak (KT) ili ga barem lak{e kontrolirati u ve}em broju bolesnika na redovitoj hemo-
dijalizi (HD). U ve}ini slu~ajeva se oslanjamo na sam HD postupak putem kojeg postepeno uklanjamo vi{ak teku}ine
tijekom nekoliko dana do tjedana, sve dok ne postignemo suhu te`inu. Postoji nekoliko metoda kojim se poku{ava {to
preciznije odrediti suhu te`inu, a najnovija i najiteresantnija me|u njima je metoda multifrekvencijske bioimpendan-
cijske spektroskopije. U na{em prospektivnom istra`ivanju smo primjenili navedenu metodu u 65 HD bolesnika da bi
dijagnosticirali povi{eni KT ovisan o volumenu te da bi preciznije odredili suhu te`inu zbog njegove bolje kontrole.
Suhu te`inu smo nakon mjerenja korigirali na po~etku te nakon jednog i tri mjeseca. Zadnje mjerenje smo u~inili nakon
{est mjeseci. Na{i su podatci pokazali da korekcija VS uz pomo} multifrekvencijske bioimpendancijske spektroskopije
omogu}ava bolju kontrolu VS i KT u bolesnika na redovitoj HD. Korekcija suhe te`ine uvjetuje bolju kontrolu hiper-
tenzije ovisne o volumenu.
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